Redefining Telehealth for Physical Therapy

INVEST IN IMMERGO LABS TODAY!

Immergo Labs is building a virtual reality platform that allows physical therapists (PT) to transcend the limits of telehealth and provide care to patients remotely. The company is currently pre-revenue and working to refine their prototype, based on rigorous scientific research and in collaboration with in-field practitioners, to develop a truly accessible and equitable tool for the healthcare industry.
... Show more
This Reg CF offering is made available through StartEngine Capital, LLC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.
Immergo Labs

Reasons to Invest

  • Immergo labs is building what we believe to be the world’s first virtual reality telehealth platform for physical therapists. Our system connects telehealth practitioners to patients using 3D avatars and AI-generated measurements, so that they can accurately evaluate movement and guide patients through the therapeutic process remotely.

  • Immergo is poised to tap into the $50 billion physical and occupational therapy services market in the United States which is projected to grow to over $71 billion by 2028 (source). As adoption of telehealth platforms has accelerated, hands-on therapists are in need of better tools in order to execute a level of care on par with in-person visits.

  • Immergo’s core team is composed of PhDs with expertise in computer engineering, computational media, biomechanics, and robotics –their platform is actively being co-designed based on the qualitative evidence and feedback of over 200 therapists working  in the physical therapy industry worldwide. This led to a quarter million dollar award from the U.S. National Science Foundation to develop this platform for profound societal impact.


overview


Tools for Navigating Tomorrow’s Telehealth Landscape


Immergo Labs is a people-first company with a mission to support physical therapists and provide them with the best possible tools to do their job. Throughout our work conducting research, surveys, and interviews with practitioners, we’ve learned that one of the most pressing concerns facing today’s PT professionals is adapting to a telehealth model for providing care. Rather than replacing the human connection that is critical to the industry, we’re developing technology that helps therapists overcome these challenges and do more of what they love to do, which is help people.


Immergo's Demo video from the American Physical Therapy Association February 2022 Combined Section Meeting:


*The above is a rendering of a future product. Images are computer generated demo versions. Product is still currently under development and is not yet available on the market.


the problem & our solution


Telehealth Without Compromising Quality of Care


For anyone recovering from an injury or surgery, looking to overcome pain, or increase functional mobility, physical therapy (PT) is a powerful tool that helps millions of people (source). However, for therapists who have traditionally practiced hands-on in a treatment room, telehealth platforms have proven limiting (source). For physical rehabilitation to be successful, providers need to be able to see their patients move, accurately assess their progress, and intuitively guide them through the recovery process both in person and remotely.


*The above is a rendering of a future product. Images are computer generated demo versions. Product is still currently under development and is not yet available on the market.


As a solution, Immergo has built an all-in-one virtual platform where therapists can practice remotely, yet still access the critical insights needed to provide quality care. The software allows them to monitor patient avatars in real-time or holograms remotely with a simple VR setup while also measuring strength, balance, and range-of-motion metrics in the process. Using the Immergo platform, clinicians will have the ability to implement a hybrid model, and offer remote visits as an extension of their in-person care, as well as run their own virtual clinics independently, to reach clients anywhere with the metaverse.


*The above is a rendering of a future product. Images are computer generated demo versions. Product is still currently under development and is not yet available on the market.

the market & our traction


At The Intersection of Research and Real Life Application

(source & source)


Immergo’s very first investor was the National Science Foundation, who provided $256K in funding for initial development. This support has allowed our team to translate over six years of extensive research regarding the biomechanics of rehabilitation and develop our own machine learning algorithms. We’ve also used this time to refine the user experience based on our understanding of issues facing the physical therapy industry.




*The above is a rendering of a future product. Images are computer generated demo versions. Product is still currently under development and is not yet available on the market.

On the heels of these efforts, Immergo has licensed one patent from the University of Santa Cruz, applied for a separate non-provisional patent and secured important partnerships in the process. We are currently partnering with the Department of Veterans Affairs, to bring this type of remote care to VA patients, and have been connected with the American Physical Therapy Association- the largest PT organization in the United States for two years. At a recent APTA conference, initial demos of the technology were met with positive response, and as a result, the waiting list for access to our platform continues to grow.


*The above testimonials may not be representative of the opinions of other medical experts or experiences of other customers and is not a guarantee of future performance or success

why invest


Let's Bring Meaningful Solutions to the Metaverse


Although Immergo is rapidly gaining traction between proof of concept, emerging partnerships and planned product testing, true success to us is about actually getting our technology into the hands of therapists and patients. With the support of investors who believe in equitable, accessible care, we believe that we can begin this process in earnest, and start shaping the future of telehealth for the better. Help us pave our pathway to launch by investing with Immergo Labs, today!


*The above is a rendering of a future product. Images are computer generated demo versions. Product is still currently under development and is not yet available on the market.


Code View

ABOUT

HEADQUARTERS
250 Natural Bridges Dr
Santa Cruz, CA 95060
VALUATION
$19.48M

Immergo Labs is building a virtual reality platform that allows physical therapists (PT) to transcend the limits of telehealth and provide care to patients remotely. The company is currently pre-revenue and working to refine their prototype, based on rigorous scientific research and in collaboration with in-field practitioners, to develop a truly accessible and equitable tool for the healthcare industry.

TEAM

Michael Ora Powell
Michael Ora Powell
CEO, co-founder, biomechanics lead, & director

Michael is the Cheif Executive Officer of Immergo Labs where he leads the business and biomechanics aspects of the company. Dr Powell has recevied Bachelors' degrees in physics and kinesiology, a Master's degree in exercise science with a focus in biomechancis, and a PhD in computer engineering where his research focused on developing machine learning algorithms to estimate joint mechanincs during virtual reality rehabiltiation. Michael grew up playing sports sparking his interest in physical performance and recovery which steered his reserach for the last several years. Now he hopes to take his experience and develop tools to help others in their recovery process. 

Aviv Elor
Aviv Elor
Chief Research and Experience Officer, co-founder, UX Lead, & director

Aviv Elor is the chief research and experience officer at Immergo Labs, where he leads virtual reality development, user experience research, and product validation. He is an award-winning researcher with expertise in the design and validation of virtual environments for physical rehabilitation. Dr. Elor has previously worked in designing immersive experiences from healthcare to entertainment between mixed academic-industry channels with organizations such as the National Institutes of Health, Meta (Facebook/Oculus) Reality Labs, Google Daydream, Warner Bros Entertainment, and Walt Disney Imagineering. After rupturing his own elbow in a national judo match and undergoing reconstructive surgery, he became a passionate developer for assistive technologies towards more accessible, affordable, and accurate physical therapy tools.

Ash Robbins
Ash Robbins
Chief Technology Officer, co-founder, machine learning lead & director

Ash Robbins leads artificial intelligence design, manages cloud architecture integration, and ensures development meets technical validation. He has extensive development experience in machine learning and cloud computing from bio-inspired robotics to rehabilitation movement and modeling. He previously has worked on robots with adjustable dynamic properties and developing neural data from complex cloud architectures. His focus is on generalization in algorithmic design, using data driven approaches to quantify uncertainty. Robbins is currently a PhD Candidate at UCSC and upon graduation in 2023 will pursue commercialization of Immergo's core technology full time. Robbins works closely with Elor to lead technical operations.

Sean Wells

Sean Wells

Physical Therapy Advisor

Sean Wells, DPT, OCS, ATC, CSCS, NSCA-CPT, CNPT, CERTDN is an expert concierge PT and a member of the APTA, NATA, and NSCA. Dr. Wells owns 4 concierge PT practices, has over 10 years of private PT business experience and has led research trials in applying emerging technology to concierge patients and garnering data with products including Nike Strobe glasses, Alter G, and vibration platforms. Through his concierge PT expertise and the hands-on application of the tech for research, Dr. Wells informs the discovery of new needs, tools, or settings. 

Greg Gewickey

Greg Gewickey

Strategic Business Advisor

Greg Gewickey as a Technology Executive and Strategy Advisor at Gewickey Consulting, he engages with clients to develop robust corporate strategies. Greg has more than 35 years of industry experience in strategic planning, technology innovation, product management, and startup acceleration from organizations such as Amazon Web Services, IBM, Philips Electronics, InterActual, Walt Disney, and Warner Bros. 

Sri Kurniawan

Sri Kurniawan

User Experience and Accessibility Advisor

Sri Kurniawan is the Chair and Professor of Computational Media at UC Santa Cruz, where she leads research and development of assistive technology to help people with special needs maintain a high quality of life. Kurniawan has more than 20 years of experience in human-centered design, research collaborations with companies such as Microsoft, IBM Accessibility Lab, and others. Additionally, Kurniawan specializes in VR rehabilitation and has been involved with five NSF Basic Research Grant Projects over the past decade in designing and evaluating assistive technologies. 

Mircea Teodorescu

Mircea Teodorescu

Engineering Advisor

Mircea Teodorescu is a Professor in the Department of Electrical and Computer Engineering at University of California, Santa Cruz. He is a systems engineer and biomechanical specialist with research focus on the development of emerging technologies to improve quality of life from bioengineering, bioelectronics, and robotics. 

TERMS

Immergo Labs
Overview
PRICE PER SHARE
$2.24
DEADLINE
Dec 22, 2022
VALUATION
$19.48M
AMOUNT RAISED
$160,321.01
Breakdown
MIN INVESTMENT
$199.36
MAX INVESTMENT
$1,069,983.04
MIN NUMBER OF SHARES OFFERED
4,464
OFFERING TYPE
Equity
ASSET TYPE
COMMON
SHARES OFFERED
Common Stock
MAX NUMBER OF SHARES OFFERED
477,671

Maximum Number of Shares Offered subject to adjustment for bonus shares


Company

:

Immergo Labs, Inc.

Corporate Address

:

250 Natural Bridges Dr, Santa Cruz, CA 95060

Offering Minimum

:

$9,999.36

Offering Maximum

:

$1,069,983.04

Minimum Investment Amount

(per investor)

:

$199.36











Terms


Offering Type

:

Equity

Security Name

:

Common Stock

Minimum Number of Shares Offered

:

4,464

Maximum Number of Shares Offered

:

477,673

Price per Share

:

$2.24

Pre-Money Valuation

:

$19,478,258.24











*Maximum number of shares offered subject to adjustment for bonus shares. See Bonus info below.

Time-Based:

Friends and Family Early Birds

Invest within the first 48 hours and receive an additional 20% bonus shares.

Super Early Bird Bonus

Invest within the first week and receive an additional 10% bonus shares.

Early Bird Bonus

Invest within the first ten days and receive an additional 5% bonus shares.


Amount-Based:

$200 | Tier 1

Priority access and support to Immergo Beyond Platform for 1 Year after Launch 

$500+ | Tier 2

2% bonus shares, Immergo T-Shirt, + all perks from previous tiers

$1,000+ | Tier 3

3% bonus shares, Immergo Hoodie, + all perks from previous tiers

$2,500+ | Tier 4

5% bonus shares, mention on Immergo Website (if desired), Immergo founders club certificate, + all perks from previous tiers

$5,000+ | Tier 5

7% bonus shares, Video call with the founders, + all perks from previous tiers

$10,000+ | Tier 6

10% bonus shares, Access to Immergo Beyond Alpha Platform & VR Meetup with the Founders, + all perks from previous tiers

$20,000+ | Tier 7

15% bonus shares, Tour of the Company & A day in Santa Cruz with the Co-Founders, Go Surfing with our Co-Founder Ash in the famous Steamer’s Lane, Try local foods at the famous Santa Cruz Boardwalk, Hike in the redwood forest to the beach, Crawl of popular breweries and hidden local beaches, + all perks from previous tiers

*In order to receive perks from an investment, one must submit a single investment in the same offering that meets the minimum perk requirement. Bonus shares from perks will not be granted if an investor submits multiple investments that, when combined, meet the perk requirement. All perks occur when the offering is completed.


The 10% StartEngine Owners' Bonus

Immergo Labs will offer 10% additional bonus shares for all investments that are committed by investors that are eligible for the StartEngine Crowdfunding Inc. OWNer's bonus.

This means eligible StartEngine shareholders will receive a 10% bonus for any shares they purchase in this offering. For example, if you buy 100 shares of Common Stock at $2.24 / share, you will receive 110 shares of Common Stock, meaning you'll own 110 shares for $224. Fractional shares will not be distributed and share bonuses will be determined by rounding down to the nearest whole share.

This 10% Bonus is only valid during the investor's eligibility period. Investors eligible for this bonus will also have priority if they are on a waitlist to invest and the company surpasses its maximum funding goal. They will have the first opportunity to invest should room in the offering become available if prior investments are canceled or fail.

Investors will receive the highest single bonus they are eligible for among the bonuses based on the amount invested and time of offering elapsed (if any). Eligible investors will also receive the Owner’s Bonus in addition to the aforementioned bonus.

Irregular Use of Proceeds

The Company will not incur any irregular use of proceeds.

PRESS

Article Image
Santa Cruz Works

Recap of Startup Rumble New Tech

Article Image
Santa Cruz Works

Immergo Labs Secures Major Partnerships and Initial Investors to Support Physical Therapy in the Metaverse

Article Image
Santa Cruz Works

Santa Cruz Accelerates #26: Immergo LLC

Article Image
XR Inclusion

XR Creator Spotlight: Aviv Elor, Co-Founder & Lead Investigator, Immersive Labs

Article Image
The Tech Tribune

2022 Best Tech Startups in Santa Cruz










ALL UPDATES

11.21.22

Immergo Labs Demos at Born in California!

Born in California, an invitation-only startup demo day event hosted by UC Irvine. This year's Nov. 16-17 event featured 40 startups representing all ten University of California campuses' best and most investment-worthy companies seeking Seed and Series A investors.

Immergo Labs had the opportunity to represent UC Santa Cruz.  It was fantastic to present to such a diverse crowd of entrepreneurs and investors.  We are thankful to be a part of the UC community.  The feedback and responses we received were great.  Many shared their personal experiences of physical therapy and how our platform could have helped them through their rehabilitative process.  We are excited for the future of Immergo and look forward to helping others through their rehabilitative process!

Thank you UC Irvine Beall Applied Innovation, US Bank, and Sunstone for putting together this opportunity!


11.16.22

Meet the Immergo Labs Team!

We’d love to introduce you to Immergo Labs' Strategic Advisor, Dr. Sean Wells who provides physical therapy guidance for the team, design considerations, business advice focused on cash based practices, and platform testing.  Sean is a board certified orthopedic specialist with licenses in physical therapy, athletic training, and certifications in strength and conditioning and dry needling.  Dr. Wells has experience with teaching and research at Florida Gulf Coast University and University of North Florida. Currently he owns a private, cash-based PT practice in Florida and offers online continuing education to physical therapists. When he’s not reading journals, treating patients, or tinkering in VR you can find him on the beach surfing or playing soccer.


“The future of physical therapy includes remote monitoring and immersive technologies like Immergo's VR platform. Physical therapy leadership recognizes this trend and without these tools physical therapists are going to be left behind.  As a physical therapy practice owner, having Immergo's VR platform will improve my patient engagement, outcomes, and my bottom line.” 

Dr. Sean Wells - DPT, OCS, ATC, CSCS, NSCA-CPT, CNPT, CertDN

11.10.22

Immergo Labs Joins Fogarty Innovation!

Fogarty Innovation is a nonprofit organization dedicated to advancing medical innovation that improves human health. Immergo Labs was accepted to the Company Accelerator Program where they will receive help honing their strategies, build their team, and navigate the path to commercialization. This program offers guidance from Fogarty Innovation’s engineers, directors, and entire C-suite. Immergo’s primary mentors will be Marga Ortigas Wedekind (Chief Commercial Strategy Officer) who has a rich history in bringing new solutions to the market, including in digital health, and John Morriss (Director of Innovation Acceleration) who has extensive experience in business for product development.


Immergo is thrilled and grateful to be joining this group with a proven track record of helping seed stage companies set and achieve critical growth milestones.  Immergo knows that the guidance and mentorship of this program will not only help with company success but increase access to physical rehabilitation for all!

11.08.22

Immergo Labs Attends MedHealth Summit and VentureWell ASPIRE

Last week the MedHealth Summit and VentureWell ASPIRE in-person events occurred in Detroit.  Immergo Labs attended to connect, collaborate, and learn from the other innovators.  At the MedHealth Summit, companies discussed how they are increasing access to care and improving health outcomes in Southeast Michigan and Southwest Ontario.  And at ASPIRE we learned from advisors and mentors how to grow and scale early stage companies.  We are excited to apply these learnings and forge new collaborations to help increase access to care.  


10.28.22

Lookout Santa Cruz publishes interview with Immergo Labs’ CEO


Immergo Labs was conceptualized in Santa Cruz and we appreciate all of our local support.  Thomas Sawano of Lookout Santa Cruz interviewed Michael Powell about Immergo Labs progress and goals. Take a look at the article here to get a deeper look at Immergo Labs.



 

10.25.22

Immergo Labs Selected VentureWell ASPIRE Medtech Program

Exciting news for Immergo Labs - we have been selected for the VentureWell ASPIRE Medtech Program! The program will take place over 5 weeks and we’ll be connected to industry experts for networking and mentoring opportunities as we continue to build our company. ASPIRE has helped 139+ startups like ours grow their companies and we are grateful for the opportunity to work with this great team!  

https://bit.ly/3TlY6sP

10.20.22

Immergo Labs is proud to announce our partnership with Stanford Health Care!


We are excited to announce Immergo Labs will be working with physical therapists at Stanford Health Care! The Outpatient Physical Therapy Department will trial the platform and provide feedback to assist with development, growth, and viability of Immergo. The platform will be tested with select patients in their outpatient and sports medicine rehabilitation settings.  At Immergo we always want to keep therapists and patient feedback at the forefront of our design process.  These clinical and professional perspectives are incredibly valuable and we are excited to be working with this great group of therapists.  Together we can build the future of healthcare and increase accessibility to rehabilitation!

10.12.22

Physical Therapist Testimonials

At Immergo Labs we believe that physical therapists should be involved throughout the design process.  We want to make sure we are building the platform they are looking for.  We asked two of our collaborating therapists to give their thoughts on Immergo and the use of virtual reality. We work with many physical therapists and throughout our campaign we will continue to post their feedback so you all can get an inside view.  

                                                                                              

“Immergo has the potential to be a revolutionary tool. Its developers have taken great care in soliciting and incorporating the feedback of doctors of physical therapy into the platform's design from the ground up. This means that this technology has the potential to make the delivery of care more smooth and less burdensome for therapists in settings such as outpatient clinics where customer service is a major organizational value.

I believe that if Immergo continues to execute at this rate, their virtual platform will not only free a segment of the population from having to be physically present in the clinic, it will create that feeling of belongingness and care in a virtual environment. It will also be more congruent with the on-the-go lifestyle of the coming generations. While this may be a stretch for most of the boomer generation, generations that are digital natives will easily adopt this mode of care delivery. One of the major pain points that Immergo has the potential to address is the administrative hurdles of getting referred, scheduling, and attending a PT session.”

Nima Tabloei - PT, DPT, MPH, CSCS, Board-certified specialist in neurologic physical therapy (NCS) - Orthopedic spine and neurologic

                                                                                              

“Immergo Labs technology is trail blazing the future of rehabilitation and healthcare. Enhancing the access of care via the virtual space in combination with the accuracy of capturing 3D human movements, make Immergo one of the most viable options in the industry. The application of the immersive virtual environment positively impacts our clinical practice through the early and late stages of return to sport as we retrain the brain and body whilst monitoring the postural control and performance of clients.

Virtual reality is a rapidly expanding field. Technology has yet to fully penetrate the healthcare industry and Immergo Labs is bridging this gap to expand care, provide unique physical and cognitive experience for both providers and clients, and allowing clinicians to optimize patient outcomes through sensory reweighting following injury.”

Michael Jeanfavre - PT, DPT, FAAOMPT, SCS, OCS  - Sports and Orthopedics


*The above testimonials may not be representative of the opinions of other medical experts or experiences of other customers and is not a guarantee of future performance or success

10.06.22

Demoing the Immergo Platform at the Miramar Airshow

Recently, Immergo Labs was invited by the NavalX Tech Bridges to demo at the Miramar Airshow in San Diego. This was a great 3 day event where ~450k attendees were able to watch the Blue Angels, walk through various aircrafts, and check out the companies in the Technology Expo. We met hundreds of guests including service members, veterans, physical therapists, healthcare workers, and politicians all of whom resonated with the need for improved telehealth to help increase access to care. Guests were able to try our demo and had great responses and feedback! Veterans especially loved the idea and platform as many stated there are multiple week wait times to get into the clinic as they are overloaded and improved telehealth would help alleviate the problem. The Navy has a need for an improved telehealth to help treat their active service men and women who are stationed around the world.  Having the ability to get and stay connected with a physical therapists will help reduce travel needed during rehabilitation and help improve recovery outcomes. We are excited to be developing this technology and getting it to those who need it most!


Learn more at: https://www.santacruzworks.org/news/immergo-launches-start-engine-campaign-surpasses-100k-mark


09.30.22

Over $100k of investment in the first week!

A HUGE thank you to our investors who helped us over this milestone in the FIRST week! 

In just five days, 49 investors have joined Immergo's mission towards revolutionizing telehealth! We've officially raised over $100k and are incredibly grateful to everyone who has joined us on this mission. We believe in equitable care, putting people first, and building the metaverse for good – all of this support will help us forge a new pathway to care.  

But we’re just beginning and we need your help. Please spread the word by inviting your friends & family to join us as we develop our telehealth platform. Stay tuned, we have some exciting updates to share with everyone! Lastly, please don’t hesitate to ask any questions in our comments section.

LET’S REVOLUTIONIZE TELEHEALTH!

THANK YOU!!!










Owners bonus
Stack Owner's Bonus & Rewards!

Members get an extra 10% shares in addition to rewards below!

REWARDS

Multiple investments in an offering cannot be combined to qualify for a larger campaign perk. Get rewarded for investing more into Immergo Labs.

$198.00

StartEngine Owner’s Bonus

This offering is eligible for the StartEngine Owner’s 10% Bonus program. For details on this program, please see the Offering Summary section below.

$200.00

$200 | Tier 1

Priority access and support to Immergo Beyond Platform for 1 Year after Launch.

$500.00

$500+ | Tier 2

2% bonus shares, Immergo T-Shirt, + all perks from previous tiers.

$1,000.00

$1,000+ | Tier 3

3% bonus shares, Immergo Hoodie, + all perks from previous tiers

$2,500.00

$2,500+ | Tier 4

5% bonus shares, mention on Immergo Website (if desired), Immergo founders club certificate, + all perks from previous tiers.

$5,000.00

$5,000+ | Tier 5

7% bonus shares, Video call with the founders, + all perks from previous tiers.

$10,000.00

$10,000+ | Tier 6

10% bonus shares, Access to Immergo Beyond Alpha Platform & VR Meetup with the Founders, + all perks from previous tiers.

$20,000.00

$20,000+ | Tier 7

15% bonus shares, Tour of the Company; A day in Santa Cruz w/Co-Founders, Surfing w/Co-Founder Ash, Try Local Foods at Santa Cruz Boardwalk, Hike redwood forest to the beach, Crawl of popular breweries and hidden local beaches, + all previous perks.

JOIN THE DISCUSSION













0/2500

HOW INVESTING WORKS

Cancel anytime before 48 hours before a rolling close or the offering end date.

WHY STARTENGINE?

REWARDSWe want you to succeed and get the most out of your money by offering rewards and memberships!
SECUREYour info is your info. We take pride in keeping it that way!
DIVERSE INVESTMENTSInvest in over 200 start-ups and collectibles!

With Regulation A+, a non-accredited investor can only invest a maximum of 10% of their annual income or 10% of their net worth per year, whichever is greater. There are no restrictions for accredited investors.

With Regulation Crowdfunding, non-accredited investors with an annual income or net worth less than $124,000, are limited to invest a maximum of 5% of the greater of those two amounts. For those with an annual income and net worth greater than $124,000, he/she is limited to investing 10% of the greater of the two amounts.

At the close of an offering, all investors whose funds have “cleared” by this time will be included in the disbursement. At this time, each investor will receive an email from StartEngine with their Countersigned Subscription Agreement, which will serve as their proof of purchase moving forward.

Please keep in mind that a company can conduct a series of “closes” or withdrawals of funds throughout the duration of the campaign. If you are included in that withdrawal period, you will be emailed your countersigned subscription agreement and proof of purchase immediately following that withdrawal.

StartEngine assists companies in raising capital, and once the offering is closed, we are no longer involved with whether the company chooses to list shares on a secondary market, or what occurs thereafter. Therefore, StartEngine has no control or insight into your investment after the close of the live offering. In addition, we are not permitted to provide financial advice. You may want to contact a financial professional to discuss possible investment outcomes.

For Regulation Crowdfunding, investors are able to cancel their investment at any point throughout the campaign up until 48 hours before the closing of the offering. Note: If the company does a rolling close, they will post an update to their current investors, giving them the opportunity to cancel during this timeframe. If you do not cancel within this 5-day timeframe, your funds will be invested in the company, and you will no longer be able to cancel the investment. If your funds show as ‘Invested’ on your account dashboard, your investment can no longer be canceled.

For Regulation A+, StartEngine allows for a four-hour cancelation period. Once the four-hour window has passed, it is up to each company to set their own cancelation policy. You may find the company’s cancelation policy in the company’s offering circular.

Once your investment is canceled, there is a 10-day clearing period (from the date your investment was submitted). After your funds have cleared the bank, you will receive your refund within 10 business days.

Refunds that are made through ACH payments can take up to 10 business days to clear. Unfortunately, we are at the mercy of the bank, but we will do everything we can to get you your refund as soon as possible. However, every investment needs to go through the clearing process in order to get sent back to the account associated with the investment.

Both Title III (Regulation Crowdfunding) and Title IV (Reg A+) help entrepreneurs crowdfund capital investments from unaccredited and accredited investors. The differences between these regulations are related to the investor limitations, the differing amounts of money companies are permitted to raise, and differing disclosure and filing requirements. To learn more about Regulation Crowdfunding, click here, and for Regulation A+, click here.

@ 2022 All Rights Reserved

Apple Store Logo

Get To Know Us

Our Team

Careers

Important Message

IN MAKING AN INVESTMENT DECISION, INVESTORS MUST RELY ON THEIR OWN EXAMINATION OF THE ISSUER AND THE TERMS OF THE OFFERING, INCLUDING THE MERITS AND RISKS INVOLVED. INVESTMENTS ON STARTENGINE ARE SPECULATIVE, ILLIQUID, AND INVOLVE A HIGH DEGREE OF RISK, INCLUDING THE POSSIBLE LOSS OF YOUR ENTIRE INVESTMENT.


www.StartEngine.com is a website owned and operated by StartEngine Crowdfunding, Inc. (“StartEngine”), which is neither a registered broker-dealer, investment advisor nor funding portal.


Unless indicated otherwise with respect to a particular issuer, all securities-related activity is conducted by regulated affiliates of StartEngine: StartEngine Capital, LLC, a funding portal registered here with the US Securities and Exchange Commission (SEC) and here as a member of the Financial Industry Regulatory Authority (FINRA), or StartEngine Primary, LLC, a broker-dealer registered with the SEC and FINRA/SIPC . You can review the background of our broker-dealer and our investment professionals on FINRA’s BrokerCheck here. StartEngine Secondary is an alternative trading system regulated by the SEC and operated by StartEngine Primary, LLC, a broker dealer registered with the SEC and FINRA. StartEngine Primary, LLC is a member of SIPC and explanatory brochures are available upon request by contacting SIPC at (202) 371-8300.


Investment opportunities posted and accessible through the site are of three types:


1) Regulation A offerings (JOBS Act Title IV; known as Regulation A+), which are offered to non-accredited and accredited investors alike. These offerings are made through StartEngine Primary, LLC (unless otherwise indicated). 2) Regulation D offerings (Rule 506(c)), which are offered only to accredited investors. These offerings are made through StartEngine Primary, LLC. 3) Regulation Crowdfunding offerings (JOBS Act Title III), which are offered to non-accredited and accredited investors alike. These offerings are made through StartEngine Capital, LLC. Some of these offerings are open to the general public, however there are important differences and risks.


Any securities offered on this website have not been recommended or approved by any federal or state securities commission or regulatory authority. StartEngine and its affiliates do not provide any investment advice or recommendation and do not provide any legal or tax advice with respect to any securities. All securities listed on this site are being offered by, and all information included on this site is the responsibility of, the applicable issuer of such securities. StartEngine does not verify the adequacy, accuracy or completeness of any information. Neither StartEngine nor any of its officers, directors, agents and employees makes any warranty, express or implied, of any kind whatsoever related to the adequacy, accuracy, or completeness of any information on this site or the use of information on this site. See additional general disclosures here.


By accessing this site and any pages on this site, you agree to be bound by our Terms of use and Privacy Policy, as may be amended from time to time without notice or liability.


Canadian Investors Investment opportunities posted and accessible through the site will not be offered to Canadian resident investors. Potential investors are strongly advised to consult their legal, tax and financial advisors before investing. The securities offered on this site are not offered in jurisdictions where public solicitation for offerings is not permitted; it is solely your responsibility to comply with the laws and regulations of your country of residence.


California Investors Only – Do Not Sell My Personal Information (800-317-2200). StartEngine does not sell personal information. For all customer inquiries, please write to contact@startengine.com.


StartEngine’s Reg A+ offering is made available through StartEngine Crowdfunding, Inc. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. For more information about this offering, please view StartEngine’s offering circular and risk associated with this offering.